1277 related articles for article (PubMed ID: 31941785)
1. Phase Separation of Epstein-Barr Virus EBNA2 and Its Coactivator EBNALP Controls Gene Expression.
Peng Q; Wang L; Qin Z; Wang J; Zheng X; Wei L; Zhang X; Zhang X; Liu C; Li Z; Wu Y; Li G; Yan Q; Ma J
J Virol; 2020 Mar; 94(7):. PubMed ID: 31941785
[TBL] [Abstract][Full Text] [Related]
2. Epstein-Barr Virus Nuclear Antigen Leader Protein Coactivates EP300.
Wang C; Zhou H; Xue Y; Liang J; Narita Y; Gerdt C; Zheng AY; Jiang R; Trudeau S; Peng CW; Gewurz BE; Zhao B
J Virol; 2018 May; 92(9):. PubMed ID: 29467311
[TBL] [Abstract][Full Text] [Related]
3. Hsp72 up-regulates Epstein-Barr virus EBNALP coactivation with EBNA2.
Peng CW; Zhao B; Chen HC; Chou ML; Lai CY; Lin SZ; Hsu HY; Kieff E
Blood; 2007 Jun; 109(12):5447-54. PubMed ID: 17341665
[TBL] [Abstract][Full Text] [Related]
4. EBV nuclear antigen EBNALP dismisses transcription repressors NCoR and RBPJ from enhancers and EBNA2 increases NCoR-deficient RBPJ DNA binding.
Portal D; Zhao B; Calderwood MA; Sommermann T; Johannsen E; Kieff E
Proc Natl Acad Sci U S A; 2011 May; 108(19):7808-13. PubMed ID: 21518914
[TBL] [Abstract][Full Text] [Related]
5. Four EBNA2 domains are important for EBNALP coactivation.
Peng CW; Zhao B; Kieff E
J Virol; 2004 Oct; 78(20):11439-42. PubMed ID: 15452270
[TBL] [Abstract][Full Text] [Related]
6. Conditional expression of a dominant-negative form of Epstein-Barr virus (EBV) nuclear antigen EBNALP inhibits EBV-positive lymphoblastoid cell growth.
Harada S; Saijo M
Arch Virol; 2020 Feb; 165(2):313-320. PubMed ID: 31813023
[TBL] [Abstract][Full Text] [Related]
7. The nuclear chaperone nucleophosmin escorts an Epstein-Barr Virus nuclear antigen to establish transcriptional cascades for latent infection in human B cells.
Liu CD; Chen YL; Min YL; Zhao B; Cheng CP; Kang MS; Chiu SJ; Kieff E; Peng CW
PLoS Pathog; 2012; 8(12):e1003084. PubMed ID: 23271972
[TBL] [Abstract][Full Text] [Related]
8. Epstein-Barr virus nuclear antigen 3A partially coincides with EBNA3C genome-wide and is tethered to DNA through BATF complexes.
Schmidt SC; Jiang S; Zhou H; Willox B; Holthaus AM; Kharchenko PV; Johannsen EC; Kieff E; Zhao B
Proc Natl Acad Sci U S A; 2015 Jan; 112(2):554-9. PubMed ID: 25540416
[TBL] [Abstract][Full Text] [Related]
9. Direct interactions between Epstein-Barr virus leader protein LP and the EBNA2 acidic domain underlie coordinate transcriptional regulation.
Peng CW; Xue Y; Zhao B; Johannsen E; Kieff E; Harada S
Proc Natl Acad Sci U S A; 2004 Jan; 101(4):1033-8. PubMed ID: 14732686
[TBL] [Abstract][Full Text] [Related]
10. Epstein-Barr virus nuclear antigen 2 transactivates the long terminal repeat of human immunodeficiency virus type 1.
Scala G; Quinto I; Ruocco MR; Mallardo M; Ambrosino C; Squitieri B; Tassone P; Venuta S
J Virol; 1993 May; 67(5):2853-61. PubMed ID: 8386279
[TBL] [Abstract][Full Text] [Related]
11. Epstein-Barr Virus Nuclear Antigen 3 (EBNA3) Proteins Regulate EBNA2 Binding to Distinct RBPJ Genomic Sites.
Wang A; Welch R; Zhao B; Ta T; Keleş S; Johannsen E
J Virol; 2015 Dec; 90(6):2906-19. PubMed ID: 26719268
[TBL] [Abstract][Full Text] [Related]
12. Identification of Epstein-Barr virus (EBV) nuclear antigen 2 (EBNA2) target proteins by proteome analysis: activation of EBNA2 in conditionally immortalized B cells reflects early events after infection of primary B cells by EBV.
Schlee M; Krug T; Gires O; Zeidler R; Hammerschmidt W; Mailhammer R; Laux G; Sauer G; Lovric J; Bornkamm GW
J Virol; 2004 Apr; 78(8):3941-52. PubMed ID: 15047810
[TBL] [Abstract][Full Text] [Related]
13. Epstein-Barr nuclear antigen leader protein coactivates transcription through interaction with histone deacetylase 4.
Portal D; Rosendorff A; Kieff E
Proc Natl Acad Sci U S A; 2006 Dec; 103(51):19278-83. PubMed ID: 17159145
[TBL] [Abstract][Full Text] [Related]
14. Binding of the heterogeneous ribonucleoprotein K (hnRNP K) to the Epstein-Barr virus nuclear antigen 2 (EBNA2) enhances viral LMP2A expression.
Gross H; Hennard C; Masouris I; Cassel C; Barth S; Stober-Grässer U; Mamiani A; Moritz B; Ostareck D; Ostareck-Lederer A; Neuenkirchen N; Fischer U; Deng W; Leonhardt H; Noessner E; Kremmer E; Grässer FA
PLoS One; 2012; 7(8):e42106. PubMed ID: 22879910
[TBL] [Abstract][Full Text] [Related]
15. EBNA2-EBF1 complexes promote MYC expression and metabolic processes driving S-phase progression of Epstein-Barr virus-infected B cells.
Beer S; Wange LE; Zhang X; Kuklik-Roos C; Enard W; Hammerschmidt W; Scialdone A; Kempkes B
Proc Natl Acad Sci U S A; 2022 Jul; 119(30):e2200512119. PubMed ID: 35857872
[TBL] [Abstract][Full Text] [Related]
16. Super-enhancers for RUNX3 are required for cell proliferation in EBV-infected B cell lines.
Hosoi H; Niibori-Nambu A; Nah GSS; Bahirvani AG; Mok MMH; Sanda T; Kumar AP; Tenen DG; Ito Y; Sonoki T; Osato M
Gene; 2021 Mar; 774():145421. PubMed ID: 33444684
[TBL] [Abstract][Full Text] [Related]
17. The Epstein-Barr virus EBNA-LP protein preferentially coactivates EBNA2-mediated stimulation of latent membrane proteins expressed from the viral divergent promoter.
Peng R; Moses SC; Tan J; Kremmer E; Ling PD
J Virol; 2005 Apr; 79(7):4492-505. PubMed ID: 15767449
[TBL] [Abstract][Full Text] [Related]
18. Structural and functional characterization of a complex between the acidic transactivation domain of EBNA2 and the Tfb1/p62 subunit of TFIIH.
Chabot PR; Raiola L; Lussier-Price M; Morse T; Arseneault G; Archambault J; Omichinski JG
PLoS Pathog; 2014 Mar; 10(3):e1004042. PubMed ID: 24675874
[TBL] [Abstract][Full Text] [Related]
19. The NP9 protein encoded by the human endogenous retrovirus HERV-K(HML-2) negatively regulates gene activation of the Epstein-Barr virus nuclear antigen 2 (EBNA2).
Gross H; Barth S; Pfuhl T; Willnecker V; Spurk A; Gurtsevitch V; Sauter M; Hu B; Noessner E; Mueller-Lantzsch N; Kremmer E; Grässer FA
Int J Cancer; 2011 Sep; 129(5):1105-15. PubMed ID: 21710493
[TBL] [Abstract][Full Text] [Related]
20. Phase separation of Epstein-Barr virus EBNA2 protein reorganizes chromatin topology for epigenetic regulation.
Yang Y; Ye X; Dai R; Li Z; Zhang Y; Xue W; Zhu Y; Feng D; Qin L; Wang X; Lei B; Liao S; Hao B
Commun Biol; 2021 Aug; 4(1):967. PubMed ID: 34400762
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
